NCT03894332

Brief Summary

Weaning is the entire process aimed at liberating patients from mechanical ventilation and endotracheal intubation. Weaning should be considered as early as possible in order to reduce the time spent in invasive mechanical ventilation (iMV), which is associated with morbidity and mortality. To verify if patients are ready to be extubated, a spontaneous breathing trial (SBT) is performed. At this stage some clinical indices and objective parameters are evaluated, such as the breathing pattern, gas exchange, haemodynamic stability and patient's comfort. In case of SBT success, the patient can be extubated. However, a post-extubation respiratory failure can occur within the first 48 hours after extubation, thus making extubation unsuccessful. Some patients considered at risk for post-extubation respiratory failure benefit from the application of non-invasive ventilation (NIV) after extubation. Early characterization of these patients is crucial to improve their clinical outcomes. Electrical Impedance Tomography (EIT) has been introduced in clinical practice as a non-invasive bedside monitoring tool to evaluate the aeration and ventilation of different lung regions. EIT has been proposed to guide ventilator settings adjustments in critically ill patients and to monitor prolonged weaning. However, the potential of EIT to assess SBT and after extubation in a general ICU population has never been evaluated insofar. The present study aims to describe the modifications of lung aeration, ventilation and inhomogeneity occurring during SBT and after extubation in a general population of critically ill patients at the first SBT attempt.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2016

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2016

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

February 10, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 28, 2019

Completed
Last Updated

March 29, 2019

Status Verified

March 1, 2019

Enrollment Period

1.1 years

First QC Date

February 10, 2019

Last Update Submit

March 27, 2019

Conditions

Outcome Measures

Primary Outcomes (13)

  • Change of end-expiratory lung impedance (dEELI) from baseline at first 5 minute of Spontaneous Breathing Trial (SBT_0)

    change from baseline, expressed in mL, of the end expiratory lung volume as assessed through electrical impedance tomography

    At 5 minutes of Spontaneous Breathing Trial (SBT)

  • Change of end-expiratory lung impedance (dEELI) from baseline at last 5 minute of Spontaneous Breathing Trial (SBT_30)

    change from baseline, expressed in mL, of the end expiratory lung volume as assessed through electrical impedance tomography

    At the last 5 minutes of Spontaneous Breathing Trial (SBT)

  • Change of end-expiratory lung impedance (dEELI) from baseline at first 5 minute after extubation (SB_0)

    change from baseline, expressed in mL, of the end expiratory lung volume as assessed through electrical impedance tomography

    At 5 minutes after extubation

  • Change of end-expiratory lung impedance (dEELI) from baseline at last 30 minute after extubation (SB_30)

    change from baseline, expressed in mL, of the end expiratory lung volume as assessed through electrical impedance tomography

    At 30 minutes after extubation

  • Change of tidal volume in percentage (dVt%) from baseline at last 5 minute of SBT (SBT_0)

    change from baseline, expressed in percentage, of the end expiratory lung volume as assessed through electrical impedance tomography

    At 5 minutes of spontaneous breathing trial (SBT_0)

  • Change of tidal volume in percentage (dVt%) from baseline from baseline at 30 minute of Spontaneous Breathing Trial (SBT_30)

    change from baseline, expressed in percentage, of the end expiratory lung volume as assessed through electrical impedance tomography

    At the last 5 minutes of Spontaneous Breathing Trial (SBT) (SBT_30)

  • Change of tidal volume in percentage (dVt%) from baseline after 5 minutes from extubation (SB_0)

    change from baseline, expressed in percentage, of the end expiratory lung volume as assessed through electrical impedance tomography

    At 5 minutes after extubation (SB_0)

  • Change of tidal volume in percentage (dVt%) from baseline at last 30 minute after extubation (SB_30)

    change from baseline, expressed in percentage, of the end expiratory lung volume as assessed through electrical impedance tomography

    At 30 minutes after extubation (SB_30)

  • Inhomogeneity Index (GI) at baseline

    Inhomogeneity Index (GI) as assessed through electrical impedance tomography

    At baseline during Pressure Support Ventilation

  • Inhomogeneity Index (GI) after 5 minutes of the Spontaneous Breathing Trials (SBT_0)

    Inhomogeneity Index (GI) as assessed through electrical impedance tomography

    At 5 minutes of Spontaneous Breathing Trial (SBT_0)

  • Inhomogeneity Index (GI) after 30 minutes of the Spontaneous Breathing Trials (SBT_30)

    Inhomogeneity Index (GI) as assessed through electrical impedance tomography

    At 30 minutes of Spontaneous Breathing Trial (SBT_30)

  • Inhomogeneity Index (GI) after 5 minutes from extubation (SB_0)

    Inhomogeneity Index (GI) as assessed through electrical impedance tomography

    At 5 minutes after extubation (SB_0)

  • Inhomogeneity Index (GI) after 30 minutes from extubation (SB_30)

    Inhomogeneity Index (GI) as assessed through electrical impedance tomography

    At 30 minutes after extubation (SB_30)

Secondary Outcomes (8)

  • Arterial Blood Gases at baseline

    At baseline during Pressure Support Ventilation

  • Arterial Blood Gases at SBT_30

    At 30 minutes of Spontaneous Breathing Trial (SBT_30)

  • Arterial Blood Gases at SB_30

    At 30 minutes after extubation (SB_30)

  • the ratio between respiratory rate (RR) and tidal volume (Vt) (RR/Vt) at baseline

    At baseline during Pressure Support Ventilation

  • the ratio between respiratory rate (RR) and tidal volume (Vt) (RR/Vt) at 5 minutes of Spontaneous Breathing Trial (SBT_0)

    At 5 minutes of Spontaneous Breathing Trial (SBT_0)

  • +3 more secondary outcomes

Study Arms (4)

SBT Success

Patients took part of this cohort when succeeding the Spontaneous Breathing Trial (SBT).

Diagnostic Test: Electrical Impedance Tomography (EIT)

SBT Failure

Patients took part of this cohort when failing the Spontaneous Breathing Trial (SBT). SBT Failure is defined by one or more of the following criteria occurring during the SBT: 1. loss of ≥ 2 points of Glasgow Coma Scale 2. respiratory rate/ tidal volume ≥105 breaths/min/L 3. arterial partial pressure of oxygen ≤60 mmHg on inspired oxygen fraction (FiO2) ≥0.5 and/or pH \<7.32 or a decrease in pH ≥0.07 units at the end of the SBT 4. systolic Blood Pressure \<90 mmHg or ≥180 mmHg or increased by ≥20% 5. Heart Rate \>140 beats/min or increased by 20% 6. onset of major heart arrhythmias, or electrocardiographic signs of cardiac ischemia 7. Respiratory Rate ≥35 breaths/min or increased by ≥50% 8. increased effort, respiratory distress (as indicated by diaphoresis, accessory respiratory muscles recruitment, facial signs of distress and/or paradoxical breath)

Diagnostic Test: Electrical Impedance Tomography (EIT)

Extubation Success

Patients took part of this cohort when, after extubation, did not need continuous positive airways pressure (CPAP), non invasive ventilation (NIV) or reintubation within 48 hours.

Diagnostic Test: Electrical Impedance Tomography (EIT)

Extubation Failure

Need for continuous positive airways pressure (CPAP), non invasive ventilation (NIV) or reintubation within 48 hours from extubation, as defined by: 1. Respiratory Rate \>25 breaths/min for 2 hours 2. Heart Rate \>140 beats/min or sustained increase or decrease \>20% 3. clinical signs of respiratory muscle failure 4. arterial partial pressure of oxygen (PaO2) \<80 mmHg on inspired oxygen fraction (FiO2) ≥50% 5. Arterial partial pressure of carbon dioxide \>45 mmHg with pH \<7.33

Diagnostic Test: Electrical Impedance Tomography (EIT)

Interventions

After enrollment, a silicon EIT belt of proper size with 16 electrodes was placed around the patient's chest between the 4th and 6th intercostal spaces, and connected to the EIT device. All patients were ventilated in Pressure Support Ventilation (PSV) mode, with a dedicated ventilator connected to the EIT device. We acquired 5-min EIT data records at baseline (during PSV), during the first (SBT\_0) and the last (SBT\_30) 5 minutes of SBT, and, when the patient was extubated, during spontaneous breathing soon after (SB\_0) and 30 minutes after extubation (SB\_30). EIT and ventilator data were recorded at a sample of 20 Hz. The last 3 minutes of each record were analyzed. We measured respiratory rate (RR); Vt changes from baseline, expressed as percent (dVt%); dEELI variations from baseline, expressed in mL; the Global Inhomogeneity index (GI); Impedance ratio (IR) and the Center of Ventilation (CoV).

Extubation FailureExtubation SuccessSBT FailureSBT Success

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We considered eligible any critically ill patient ≥18 years receiving invasive Mechanical Ventilation for at least 48 hours through an orotracheal tube, ready for the first Spontaneous Breathing Trial attempt, and met at least one criteria for increased risk of extubation failure.

You may qualify if:

  • Glasgow Coma Scale ≥8
  • presence of clearly audible cough during suctioning with need for tracheal suctioning ≤2/hour
  • normal sodium blood values
  • core temperature \<38.5° during the previous 8 hours
  • Arterial partial pressure of oxygen to inspired oxygen fraction (PaO2/FiO2) ≥200 mmHg, with a Positive End Expiratory Pressure ≤5 cmH2O and FiO2 ≤0.4
  • stable cardiovascular status (i.e., HR ≤140 beats/min, sBP between 90 and 160 mmHg without need for vasopressin, epinephrine or norepinephrine infusion, or with dopamine or dobutamine infusion ≤5 mcg/kg/min)
  • cuff leak volume \>110 mL

You may not qualify if:

  • major heart arrhythmias or cardiac ischemia
  • pneumothorax or emphysema
  • recent (1 week) thoracic surgery
  • presence of chest burns
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (16)

  • Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, Pearl R, Silverman H, Stanchina M, Vieillard-Baron A, Welte T. Weaning from mechanical ventilation. Eur Respir J. 2007 May;29(5):1033-56. doi: 10.1183/09031936.00010206.

    PMID: 17470624BACKGROUND
  • Nava S, Gregoretti C, Fanfulla F, Squadrone E, Grassi M, Carlucci A, Beltrame F, Navalesi P. Noninvasive ventilation to prevent respiratory failure after extubation in high-risk patients. Crit Care Med. 2005 Nov;33(11):2465-70. doi: 10.1097/01.ccm.0000186416.44752.72.

    PMID: 16276167BACKGROUND
  • Ferrer M, Sellares J, Valencia M, Carrillo A, Gonzalez G, Badia JR, Nicolas JM, Torres A. Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial. Lancet. 2009 Sep 26;374(9695):1082-8. doi: 10.1016/S0140-6736(09)61038-2. Epub 2009 Aug 12.

    PMID: 19682735BACKGROUND
  • Ferrer M, Valencia M, Nicolas JM, Bernadich O, Badia JR, Torres A. Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial. Am J Respir Crit Care Med. 2006 Jan 15;173(2):164-70. doi: 10.1164/rccm.200505-718OC. Epub 2005 Oct 13.

    PMID: 16224108BACKGROUND
  • El-Solh AA, Aquilina A, Pineda L, Dhanvantri V, Grant B, Bouquin P. Noninvasive ventilation for prevention of post-extubation respiratory failure in obese patients. Eur Respir J. 2006 Sep;28(3):588-95. doi: 10.1183/09031936.06.00150705. Epub 2006 May 31.

    PMID: 16737982BACKGROUND
  • Vianello A, Arcaro G, Braccioni F, Gallan F, Marchi MR, Chizio S, Zampieri D, Pegoraro E, Salvador V. Prevention of extubation failure in high-risk patients with neuromuscular disease. J Crit Care. 2011 Oct;26(5):517-524. doi: 10.1016/j.jcrc.2010.12.008. Epub 2011 Jan 26.

    PMID: 21273033BACKGROUND
  • Ornico SR, Lobo SM, Sanches HS, Deberaldini M, Tofoli LT, Vidal AM, Schettino GP, Amato MB, Carvalho CR, Barbas CS. Noninvasive ventilation immediately after extubation improves weaning outcome after acute respiratory failure: a randomized controlled trial. Crit Care. 2013 Mar 4;17(2):R39. doi: 10.1186/cc12549.

    PMID: 23497557BACKGROUND
  • Meade M, Guyatt G, Cook D, Griffith L, Sinuff T, Kergl C, Mancebo J, Esteban A, Epstein S. Predicting success in weaning from mechanical ventilation. Chest. 2001 Dec;120(6 Suppl):400S-24S. doi: 10.1378/chest.120.6_suppl.400s.

    PMID: 11742961BACKGROUND
  • Costa EL, Lima RG, Amato MB. Electrical impedance tomography. Curr Opin Crit Care. 2009 Feb;15(1):18-24. doi: 10.1097/mcc.0b013e3283220e8c.

    PMID: 19186406BACKGROUND
  • Frerichs I, Amato MB, van Kaam AH, Tingay DG, Zhao Z, Grychtol B, Bodenstein M, Gagnon H, Bohm SH, Teschner E, Stenqvist O, Mauri T, Torsani V, Camporota L, Schibler A, Wolf GK, Gommers D, Leonhardt S, Adler A; TREND study group. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group. Thorax. 2017 Jan;72(1):83-93. doi: 10.1136/thoraxjnl-2016-208357. Epub 2016 Sep 5.

    PMID: 27596161BACKGROUND
  • Zhao Z, Peng SY, Chang MY, Hsu YL, Frerichs I, Chang HT, Moller K. Spontaneous breathing trials after prolonged mechanical ventilation monitored by electrical impedance tomography: an observational study. Acta Anaesthesiol Scand. 2017 Oct;61(9):1166-1175. doi: 10.1111/aas.12959. Epub 2017 Aug 17.

    PMID: 28832898BACKGROUND
  • Bickenbach J, Czaplik M, Polier M, Marx G, Marx N, Dreher M. Electrical impedance tomography for predicting failure of spontaneous breathing trials in patients with prolonged weaning. Crit Care. 2017 Jul 12;21(1):177. doi: 10.1186/s13054-017-1758-2.

    PMID: 28697778BACKGROUND
  • Navalesi P, Frigerio P, Moretti MP, Sommariva M, Vesconi S, Baiardi P, Levati A. Rate of reintubation in mechanically ventilated neurosurgical and neurologic patients: evaluation of a systematic approach to weaning and extubation. Crit Care Med. 2008 Nov;36(11):2986-92. doi: 10.1097/CCM.0b013e31818b35f2.

    PMID: 18824909BACKGROUND
  • Yang KL, Tobin MJ. A prospective study of indexes predicting the outcome of trials of weaning from mechanical ventilation. N Engl J Med. 1991 May 23;324(21):1445-50. doi: 10.1056/NEJM199105233242101.

    PMID: 2023603BACKGROUND
  • Zhao Z, Moller K, Steinmann D, Frerichs I, Guttmann J. Evaluation of an electrical impedance tomography-based Global Inhomogeneity Index for pulmonary ventilation distribution. Intensive Care Med. 2009 Nov;35(11):1900-6. doi: 10.1007/s00134-009-1589-y. Epub 2009 Aug 4.

    PMID: 19652949BACKGROUND
  • Longhini F, Maugeri J, Andreoni C, Ronco C, Bruni A, Garofalo E, Pelaia C, Cavicchi C, Pintaudi S, Navalesi P. Electrical impedance tomography during spontaneous breathing trials and after extubation in critically ill patients at high risk for extubation failure: a multicenter observational study. Ann Intensive Care. 2019 Aug 13;9(1):88. doi: 10.1186/s13613-019-0565-0.

Study Officials

  • Federico Longhini

    Intensive Care Unit, University Hospital Mater Domini, Department of Medical and Surgical Sciences, Magna Graecia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 10, 2019

First Posted

March 28, 2019

Study Start

June 1, 2015

Primary Completion

June 27, 2016

Study Completion

June 30, 2016

Last Updated

March 29, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will share

The full protocol, datasets used and analysed during the current study are available on reasonable request at longhini.federico@gmail.com.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Data will be available from paper publication without any closing data